References

Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update

10.1200/jco.22.02224 · 2023 · External reference

Ateliers d’harmonisation des pratiques de la SFGM-TC

10.1016/j.bulcan.2016.09.006 · 2016 · External reference

Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation

10.1111/tid.12345 · 2015 · External reference

Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients

10.1038/bmt.2014.37 · 2014 · External reference

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

10.1007/s00277-016-2711-1 · 2016 · External reference

Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation

10.1093/cid/ciz1082 · 2020 · External reference

Antimicrobial prophylaxis in adults and children undergoing hematopoietic cell transplantation: 2021 Polish recommendations

10.5603/ahp.a2021.0097 · 2021 · External reference

Unresolved reference

2024 · External reference

Microbiology and risk factors for hospital-associated bloodstream infections among pediatric hematopoietic stem cell transplant recipients

10.1093/ofid/ofaa093 · 2020 · External reference

Infections and risk factors for infection-related mortality after pediatric allogeneic hematopoietic stem cell transplantation in Mexico: A single center retrospective study

10.1371/journal.pone.0284628 · 2023 · External reference

Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis

10.1038/bmt.2017.14 · 2017 · External reference

8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation

10.1016/s1470-2045(20)30725-7 · 2021 · External reference

Prophylaxie des infections post-allogreffe : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

10.1016/j.bulcan.2018.08.017 · 2019 · External reference

Strategies for empiric management of pediatric fever and neutropenia in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review of randomized trials

10.1200/jco.2015.65.8591 · 2016 · External reference

Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia

10.1016/s1473-3099(25)00619-x · 2026 · External reference

Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial

10.1016/s2352-3026(17)30211-9 · 2017 · External reference

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America

10.1093/cid/cir073 · 2011 · External reference

Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)

10.3324/haematol.2013.091330 · 2013 · External reference

Levofloxacin versus ciprofloxacin-based prophylaxis during the pre-engraftment phase in allogeneic hematopoietic stem cell transplant pediatric recipients: a single-center retrospective matched analysis

10.3390/antibiotics10121523 · 2021 · External reference

Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial

10.1001/jama.2018.12512 · 2018 · External reference

Levofloxacin prophylaxis in pediatric oncology and hematopoietic stem cell transplantation: a literature review

10.1080/08880018.2024.2353888 · 2024 · External reference

[Vaccination of allogeneic haematopoietic stem cell transplant recipients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]

10.1016/j.bulcan.2023.05.007 · 2024 · External reference

Clostridioides difficile infection and risk of acute graft-versus-host disease among allogeneic hematopoietic stem cell transplantation recipients

10.1016/j.jtct.2020.10.009 · 2021 · External reference

Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients

10.1093/cid/cir1035 · 2012 · External reference

Unresolved reference

External reference

Guideline for the management of Clostridioides difficile infection in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2024 update

10.1016/j.eclinm.2024.102604 · 2024 · External reference

Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults

10.1093/cid/ciab549 · 2021 · External reference

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

10.1016/j.cmi.2021.09.038 · 2021 · External reference

Unresolved reference

External reference

Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial

10.1016/j.eclinm.2023.102111 · 2023 · External reference

Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract

10.1182/bloodadvances.2024012556 · 2024 · External reference

Gut microbiome modulation and faecal microbiota transplantation following allogenic hematopoietic stem cell transplantation

10.3390/cancers13184665 · 2021 · External reference

Fecal microbiota transfer in acute graft-versus-host disease following allogeneic stem cell transplantation

10.1159/000538303 · 2024 · External reference

Dose optimization of β-lactams antibiotics in pediatrics and adults: A systematic review

10.3389/fphar.2022.964005 · 2022 · External reference

Unresolved reference

External reference

Définitions et implications des paramètres pharmacocinétiques-pharmacodynamiques des antibiotiques en pratique clinique pédiatrique

2024 · External reference

Principes de l’antibiothérapie curative

2024 · External reference

Intravenous administration of antibiotics by prolonged and continuous infusion

10.1016/j.idnow.2024.105018 · 2025 · External reference

Searching high and low: call for a Joint European Society for Paediatric Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing Survey on dosage of antibacterial agents in children—Part One

10.1097/inf.0000000000003457 · 2022 · External reference

Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation

10.1093/cid/cis580 · 2012 · External reference

Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease

10.1016/j.bbmt.2014.01.030 · 2014 · External reference

Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation

10.1186/s40168-021-01100-2 · 2021 · External reference

Gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) in pediatrics: A systematic review

10.1016/j.trim.2025.102199 · 2025 · External reference

Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice

10.1126/scitranslmed.aaf2311 · 2016 · External reference

The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation

10.1080/2162402x.2016.1258506 · 2017 · External reference

Variability in meropenem distribution and clearance in children with sepsis: population-based pharmacokinetics with assessment of renal biomarkers

10.1007/s40262-025-01495-3 · 2025 · External reference

10.1093/ajhp/zxaa036

10.1093/ajhp/zxaa036 · 2020 · External reference